New York


Drug Corporation Evades Patent Law to Sustain Profit, Stifle Democracy

October 16, 2017

The big pharma corporation, Allergan, tried an ingenious way to put its patents where U.S. law couldn’t reach them.

BREAKING NEWS: A federal judge in the Eastern District of Texas invalidated four Allergan patents associated with Restasis in a decision made on October 16, 2017.

“Sovereign immunity should not be treated as a monetizable commodity that can be purchased by private entities as part of a scheme to evade their legal responsibilities,” the judge wrote.

Press Coverage